ANDA 63274, held by Hikma. Amikacin Sulfate.
As of Nov 16, 2026, ANDA 63274 (Amikacin Sulfate), held by Hikma, was first approved by FDA on May 18, 1992, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 18, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Amikacin SulfateEQ 50MG BASE/ML · injectable;injection | Amikacin Sulfate | Discontinued |
| Jan 31, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 20, 1993 | Supplement 1Manufacturing | Approved | None posted |
| May 18, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters